SOURCE: Solos Endoscopy, Inc.

December 19, 2007 08:45 ET

Solos Endoscopy, Inc. Announces Upcoming Interview With Current Board Member on

BOSTON, MA--(Marketwire - December 19, 2007) - Solos Endoscopy, Inc. (PINKSHEETS: SLSY) today announce that current Board member, Dom Gatto, will be featured in an exclusive interview with scheduled for December 20, 2007. The interview will be posted on by 8 p.m. EST on December 20th.

The interview will cover topics including Solos Endoscopy's market potential, growth initiatives, competitive edge, recent news, and milestones for which investors should watch.

To hear the interview in its entirety, visit and click on "Interviews." The interview can be accessed by locating the company's ticker symbol (SLSY) under the appropriate exchange at the top of the "Interviews" section or by entering the company's ticker symbol in the Search Archive window.

Solos Endoscopy recently announced that the Company has completed its third quarter financials and has realized a 16% increase in sales over the same period last year. Part of the growth was attributed to growing interest in Solos Endoscopy's' breast endoscopy product line.

About Solos Endoscopy, Inc.:

Solos Endoscopy, Inc. is a healthcare technology company whose mission is to develop and market breakthrough technology, applications, medical devices, and procedural techniques for the screening, diagnosis, treatment and management of medical conditions. Backed by technical support, Solos' sales team can help make the right buying decisions for the hospital, surgery center, or physician office. Additional information is available on the Company's website at:

About is owned and operated by WallStreet Direct, Inc., a wholly owned subsidiary of Financial Media Group, Inc. The Website is a leading provider of timely business news, executive interviews, multimedia content, and research tools. Financial Media Group, Inc. also owns, a financial social network for investors, Financial Filings Corp., a provider of compliance solutions to publicly traded companies, and WallStRadio, a business and finance podcast Website. Financial Filings Corp. is expecting to receive two hundred eighty dollars from ReBuilder Medical Technologies, Inc. for the dissemination of this press release. For a complete list of our advertisers and advertising relationships, visit

Safe Harbor: This release includes forward-looking statements within the meaning of Section 27A of the Securities Act of 1933 and Section 27E of the Securities Act of 1934. Statements contained in this release that are not historical facts may be deemed to be forward-looking statements. Investors are cautioned that forward-looking statements are inherently uncertain. Actual performance and results may differ materially from that projected or suggested herein due to certain risks and uncertainties including, without limitation, ability to obtain financing and regulatory and shareholder approval for anticipated actions.

Contact Information